Physician profile
Ann M Walker
NPI 1740747435
$454.54
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.21 · 2022: $267 · 2023: $14.28 · 2024: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $103.20 | 2024 | Auvelity |
| Abbvie INC. | $51.98 | 2021-2022 | |
| Lilly USA, LLC | $49.67 | 2022-2024 | Zepbound, Mounjaro |
| Pfizer INC. | $47.21 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $38.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.04 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.63 | 2022 | |
| Novo Nordisk INC | $22.14 | 2022 | |
| Sumitomo Pharma America, INC. | $19.90 | 2024 | Gemtesa |
| Supernus Pharmaceuticals, INC. | $15.51 | 2022 | |
| Amgen INC. | $14.28 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.